Sepsis continues to be a major cause of morbidity, mortality, and post-recovery disability in patients with a wide range of non-infectious and infectious inflammatory disorders, including COVID-19. The clinical onset of sepsis is often marked by the explosive release into the extracellular fluids of a multiplicity of host-derived cytokines and other pro-inflammatory hormone-like messengers from endogenous sources ("cytokine storm"). In patients with sepsis, therapies to counter the pro-inflammatory torrent, even when administered early, typically fall short. The major focus of our proposed essay is to promote pre-clinical studies with hCG (human chorionic gonadotropin) as a potential anti-inflammatory therapy for sepsis.
Keywords: anti-inflammatory; cytokine storm; human chorionic gonadotrophic hormone (hCG); inflammation; sepsis.
Copyright © 2021 Yoo, Mehdi, Pusapati, Mathur, Anipindi, Lunenfeld, Lowell, Yang, Metz, Khan, Leroith and Roth.